Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
20 results
D3.01 - Association between allergen-related antibodies and clinical phenotypes of IgG4-related disease (IgG4-RD)
D3.02 - A Well-Established Drug and A Rare Reaction: Successful Desensitization to Adalimumab
D3.04 - Sensitization Pattern and Characteristics of IgE Repertoire in Allergic Children with Excessively High Serum IgE Levels
D3.13 - Molecular characterization of food allergens in a case of suspected honey and mustard allergy
D3.14 - IgE sensitisation to parvalbumin, Ani s 1, tropomyosin and arginine kinase delineates distinct molecular endotypes of seafood allergy
D3.03 - Titanium allergy – from anamnesis to diagnosis
D3.06 - Comparative Evaluation of Raw, Blanched, Individual and Composite Allergen Preparation for Basophil Activation Testing
D3.07 - Low inter-lot variability and high long-term stability of ready-to-use and room temperature-stable dry reagents for Basophil Activation Testing against peanut extracts
D3.08 - Biomarker Profiles and Autoimmune Features in Patients with Chronic Urticaria: A Clinical–Laboratory Analysis
D3.09 - Cyto-LTT as a Diagnostic Tool in Acute Drug-Induced Interstitial Nephritis: A Case Report and Laboratory Case Series
D3.10 - An exploratory assessment of biological inflammatory markers found in nasal epithelial cells from rhinitic patients as prospective predictors of rhinitis exacerbation status
D3.11 - Identification of allergens in Chicken and Rabbit meat, a case report
D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial
D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial
D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial
D3.447 - Pre-clinical Toxicology and Immunogenicity Evidence as a Precursor of the Successful Phase I/IIA Study with VLP Peanut
D3.448 - Use of Sebetralstat as Short-term Prophylaxis for Patients with Hereditary Angioedema: Results from the KONFIDENT-S Study
- D3.545 - Natural Killer and Dendritic Cells Leverage Synergistic Interactions to Enhance Treatment of Non-Small Cell Lung Cancer
- D3.547 - Clinical Outcomes and Safety of Drug Desensitization in Chemotherapy-Induced Hypersensitivity
- D3.548 - Refractory and persistent pruritus in an atopic patient: A red flag for underlying malignancy?
Download the app
The congress at your fingertips
Available on
Download